Hb opathy screening pilot l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 48

Hb’opathy Screening Pilot PowerPoint PPT Presentation


  • 201 Views
  • Uploaded on
  • Presentation posted in: General

Hb’opathy Screening Pilot. Dr Michael Hamon Consultant Haematologist Derriford Hospital Plymouth [email protected] Hb’opathy Screening Pilot. Hb function O 2 / CO 2 transport Globin chains reconfigure according to O 2 presence central pocket opens with O 2 release

Download Presentation

Hb’opathy Screening Pilot

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Hb opathy screening pilot l.jpg

Hb’opathy Screening Pilot

Dr Michael Hamon

Consultant Haematologist

Derriford Hospital Plymouth

[email protected]


Hb opathy screening pilot2 l.jpg

Hb’opathy Screening Pilot

Hb functionO2 / CO2 transport

  • Globin chains reconfigure according to O2 presence

  • central pocket opens with O2 release

    b chains move apart g 2,3 DPG

    fits in pocket g i’d O2 affinity

    These interactions achieve “sigmoid” curve


Slide3 l.jpg

Hb is packaged in the red blood cell

640 x 106 molecules / cell

survival 120 days


Hb opathy screening pilot4 l.jpg

Hb’opathy Screening Pilot

8 m diameter ;

capillaries 3m

flexible

biconcave discs


Hb opathy screening pilot5 l.jpg

Hb’opathy Screening Pilot

Hb genetics

Chromosome 11b(e g d b)

Chromosome 16a(z a a)

EmbryonicGower 1 (z2e2), Portland (z2g2), Gower 2 (a2e2)

FetalHbF (a2g2)

AdultHbA (a2b2) 96%

HbA2 (a2d2) ~2-3%, HbF <1%


Slide6 l.jpg

Site of

haemopoiesis

Liver

Yolk

sac

Bone marrow

spleen

Birth

20

40

HbF (a2g2)

HbA (a2b2)


Hb opathy screening pilot7 l.jpg

Hb’opathy Screening Pilot

  • HbF promotes O2 passage across placenta

  • Fetus has high Hb (20+ g/dl) successful “parasite”

  • Neonatal period

    HbF g HbA

Left shift;

Hb F has

h’d O2

affinity


Hb opathy screening pilot8 l.jpg

Hb’opathy Screening Pilot

  • globin genetics exceptional

    x4 a / person ie x2 / chromosome 16;

    1-2 deletions benign

  • 3 deletions intermittent haemolysis

  • 4 deletions (hydrops foetalis) death in utero

    a+ thal 1 gene present

    a0 thal – chr 16 lacks functional a gene


Hb opathy screening pilot9 l.jpg

Hb’opathy Screening Pilot

a0 thalassaemia

Far EastChina

Thailand

Vietnam

UncommonGreek

Italian

a+ thalassaemiaAfro Caribbean

Arab


Hb opathy screening pilot10 l.jpg

Hb’opathy Screening Pilot

Initial blood making from 2/40’s onwards

HbF main form after 1st trimester (13/40)

a0a0 can get by till ~14/40’s

Hydrops foetalisalpha thal,

severe HDN

in utero blood failure (not fully understood)

HDN Haemolytic Disease of the Newborn; typically Rhesus anti D


Hb opathy screening pilot11 l.jpg

Hb’opathy Screening Pilot

Hydrops foetalis

h’ing anaemia

h’ing red cell production

Liver g ++ expansion “erythron”

g impaired liver function


Hb opathy screening pilot12 l.jpg

Hb’opathy Screening Pilot

Hydrops foetalis

severe anaemia g heart failure

liver failure g low albumen

anasarca – whole body oedema, still birth of macerated fetus

Recurrent fetal loss; 14-18/40’s alpha thal

Hb Bart’stetramer g4


Hb opathy screening pilot13 l.jpg

Hb’opathy Screening Pilot

  • Hb variants – detection is by HPLC (screen) and electrophoresis

  • Macromolecules separated by electric

    charge (e) / mass (m); (mobility = e/m)

    pKa of different amino acids

    pH dependent differences in e/m

    HPLC High performance Liquid Chromatography


Hb opathy screening pilot14 l.jpg

Hb’opathy Screening Pilot

H

NH2

C

COOH

R

R = CH2-CH2- COOHglutamic acid (glu)

CH3

valine (val)

R = CH

CH3


Hb opathy screening pilot15 l.jpg

Hb’opathy Screening Pilot

  • HbA g HbS b6 glu g val;

  • with hpH (less H+in vitro) weak acid (glu) more (-ve) e on Hb A cf HbS

  • with lower pH glu (COOH) not charged

  • HbCb6 glu g lys } Hb C / E same position

  • HbEb26 glu g lys } pH 8.9, separate pH 6.0


Hb opathy screening pilot16 l.jpg

Hb’opathy Screening Pilot

Alkali pH 8.9

Acid pH 6.0

-

+

Hb Bart’s

HbF

HbA

HbA, D, E

Origin

HbF

HbS, HbD

HbS

HbA2; HbE,HbC

HbC

+

Origin

-

Hb electrophoresis


Hb opathy screening pilot17 l.jpg

Hb’opathy Screening Pilot

F

A

A

A

F

S

S

C

C

HbA2

S/S

A/S


Hb opathy screening pilot18 l.jpg

Hb’opathy Screening Pilot

Hardy Weinberg

Population genetics

p+q = 1; gene frequency p/q

p2+ 2pq + q2 = 1;

(p2 homoz p, 2pq heteroz, q2 homoz q)


Hb opathy screening pilot19 l.jpg

Hb’opathy Screening Pilot

  • Hardy Weinberg defined in a population in equilibrium p2 + 2pq + q2 = 1 provided

    • Random mating

    • No migration

    • No selection


Hb opathy screening pilot20 l.jpg

Hb’opathy Screening Pilot

  • Over >10,000 years malaria => life cycle impaired in individuals with heterozygosity for a thal, b thal, HbS, Hb C, HbE, HbD

  • Incidence within populations reflects previousmalaria (common in Greece / Italy until 100 years ago)


Hb opathy screening pilot21 l.jpg

Hb’opathy Screening Pilot

Central Indochina

85%either HbE, a thal +/or b thal

Human geneticists using Hardy Weinberg principle estimate where malaria holoendemic g breeding advantage for HbAS

“selection factor”HbAA0.9

HbAS1.0

HbSS<0.1


Hb opathy screening pilot22 l.jpg

Hb’opathy Screening Pilot

a thalFar east, rarely Italy / Greece

b thalGreece, Italy, Ind./ Pak., Far east

Hb Ssub Saharan Africa, India, Arab

Hb CGambia

HbEFar east, Bangladesh

HbDIndia


Hb opathy screening pilot23 l.jpg

Hb’opathy Screening Pilot

HbASwith Plasmodium falciparum 2-8x h’d clearance of parasitised cells (cf HbAA)

Heterozygote at a BIG advantage


Hb opathy screening pilot24 l.jpg

Hb’opathy Screening Pilot

a & b Thal


Hb opathy screening pilot25 l.jpg

Hb’opathy Screening Pilot

Thalassaemiaimbalance of a : b (1:1) ratio

Leads to moderate microcytosis (i’d MCV) mimicking Fe deficiency (check ferritin)

athal MCV i’s with no. of missing genes aNa+ MCV ~70

a0aN or a+a+ MCV ~62

a0a+ MCV ~56

aN both a genes normal on chr 16


Hb opathy screening pilot26 l.jpg

Hb’opathy Screening Pilot

HbS

HbC


Hb opathy screening pilot27 l.jpg

Hb’opathy Screening Pilot

HbD

HbE

HbS


Hb opathy screening pilot28 l.jpg

Hb’opathy Screening Pilot

Natural Selection (Darwinian survival of fittest)

Malarial parasite disadvantaged

InvasionOvalocytosis (membrane abnormality – Pacific), blood groups

GrowthHbS, HbE, a thal, b thal, G6PD-

ReleaseHbCC

All seen where malaria has been for generations

Eg b thal / HbS in Italy / Greece


Hb opathy screening pilot29 l.jpg

Hb’opathy Screening Pilot

World wide 150 million b thal carriers

18% Cypriots, 13% Sardinians are b thal carriers

Thalassaemia“blood from the sea” – severe / progressive anaemia

As with all chromosome 11 b globin abnormalities essentially silent until ~6/12’s of age (HbF g HbA)


Hb opathy screening pilot30 l.jpg

Hb’opathy Screening Pilot

Sickle cell syndromes

SSSCSDSESbthal

Progressive haemolytic anaemia (shortened red cell survival) / failure to thrive from 6/12’s age

Thalassaemia“blood from the sea”

b thal major severe anaemia, growth failure

b thal-HbE severe anaemia

a thal as above


Hb opathy screening pilot31 l.jpg

Hb’opathy Screening Pilot

Screening

> 30 years UK all neonates PKU, T4-

Effective treatment when found, would be missed without screening

Guthrie card

Both g irreversible developmental damage if missed

PKU phenylketonuria, T4- (hypothyroidism)


Hb opathy screening pilot32 l.jpg

Hb’opathy Screening Pilot

3 years agoNHS plan; not much for paediatrics / ethnic minority

Screen for all Hb variants / thalassaemia

All mothersmidwives document ethnic origin both parents; blood count (esp MCH / ferritin) g HPLC / Hb electrophoresis

All neonatesg Hb electrophoresis on Guthrie card (cystic fibrosis to follow)


Hb opathy screening pilot33 l.jpg

Hb’opathy Screening Pilot

Family Origin Questionnaire

1 page A4 – midwives capture parental ethnic background(s) to inform screening process

Terminology agreed with Bishop of York


Slide34 l.jpg

Column

Flow

Sample B : weak

Interaction, moves fast

Peak

Height

Retention Time


Slide35 l.jpg

Assay Principle of G7 (1)

The detector only detects the

red proteins in the sample by

working at 415 and 510nm

Column

Sample Injection

Detector

2

3

low

high

salt concentration


Slide36 l.jpg

Non-porous polymer

Porous polymer

(TSKgel G7 HSi)

(TSKgel GLYCO HS)


Slide39 l.jpg

Hb A/S

Hb S/S

Hb S/C


Hb opathy screening monthly figures 2004 to 2006 l.jpg

Hb’opathy Screening Monthly Figures 2004 to 2006.

Pre pilot

ANC 7 / month

Post pilot

ANC 60 / month


Hb opathy screening pilot43 l.jpg

Hb’opathy Screening Pilot

Effective where high incidence of abnormalities

Cyprushigh awareness of cost

consumes much of health care budget

church / state / publicmotivated

Pre marital, pre conceptual, early pregnancy


Hb opathy screening pilot44 l.jpg

Hb’opathy Screening Pilot

Cyprusp2 +2pq + q2=1

18% heterozygotes; p=0.9

81% normal, 18% carriers, 1% affected

~5% (1:2000) expected b thal majors ie 95% “prevention” – effective public health


Hb opathy screening pilot45 l.jpg

Hb’opathy Screening Pilot

b thal Di’d MCV, raised HbA2 (>3.5%) embryob gene silent

chorionic villus sampling (cvs) ~ 8-10/40’s

“appropriate” termination <13/40’s

Polymerase chain reaction (PCR)

54 molecular variants (51 point mutations, 3 deletions) = 99.9% b thal

D diagnosis


Hb opathy screening pilot46 l.jpg

Hb’opathy Screening Pilot

Molecular / genetic anthropology

Standard haematology all b thal the same (iMCV / h HbA2)

PCR recalls migrations across Mediterranean over last 3000 years

b039 west Med (Sardinia / Spain / Portugal)

b+110 east Med (Turks / Cyprus / Lebanon)


Hb opathy screening pilot47 l.jpg

Hb’opathy Screening Pilot

b039 Phoenician civilisation 12-11C BC

b+ 110 Greek occupation8-7 C BC

With any given ethnic origin up to 6 pcr primers >98% detection using cvs within 2-3 days

Asian Indians

5 alleles = 90% mutations; only 1 shared with Med top 6; in Asians molecular homozygosity common (consanguinity / distinct to given area)


Hb opathy screening pilot48 l.jpg

Hb’opathy Screening Pilot

Know ethnic origin test parents

define pcr system termination if +ve

In UK SW peninsula since Jan 2005 40 carriers, mostly Hb S or a thal in >12000 births

In Plymouth 60,000 births 14 years no disease

BewareI’m cynical;Asylum seekers


  • Login